Final Agenda

Wednesday, July 1, 2020

EDRN Steering Committee Meeting (All Times EDT)

10:00 a.m. - 10:10 a.m. EDT	Opening of June 2020 EDRN Steering Committee Meeting Joshua LaBaer, M.D., Ph.D., Arizona State University/The Biodesign Institute
10:10 a.m. - 10:20 a.m. EDT	SC01: State of the EDRN Sudhir Srivastava, Ph.D., M.P.H., National Cancer Institute
10:20 a.m. - 10:35 a.m. EDT	SC02: EsoCheck and EsoGuard Sanford Markowitz, M.D., Case Western Reserve University
10:35 a.m. – 10:40 a.m. EDT	Q&A
10:40 a.m. – 12:00 p.m. EDT	Collaborative Group Reports
10:40 a.m. – 10:55 a.m. EDT	SC03: Gastrointestinal and Other Cancers Brian Haab, Ph.D., Van Andel Research Institute Robert Schoen, M.D., M.P.H., University of Pittsburgh
10:55 a.m. – 11:00 a.m. EDT	Q&A
11:00 a.m. – 11:15 a.m. EDT	SC04: Breast and Gynecological Cancers Steven Skates, Ph.D., Massachusetts General Hospital Christopher Li, M.D., Ph.D., Fred Hutchinson Cancer Research Center
11:15 a.m. – 11:20 a.m. EDT	Q&A
11:20 a.m. – 11:35 a.m. EDT	SC05: Lung and Upper Aerodigestive Cancers Pierre Massion, M.D., Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center James Herman, M.D., University of Pittsburgh Cancer Institute
11:35 a.m. – 11:40 a.m. EDT	Q&A
11:40 a.m. – 11:55 a.m. EDT	SC06: Prostate and Urological Cancers O. John Semmes, Ph.D., Eastern Virginia Medical School Martin Sanda, M.D., Emory University
11:55 a.m. – 12:00 p.m. EDT	Q&A
12:00 p.m. – 12:15 p.m. EDT	Break
12:15 p.m. – 1:05 p.m. EDT	International Partnership on Novel Resources and Initiatives Goal: Describe novel resources and initiatives relevant to EDRN. Chair: Karen Anderson, M.D., Ph.D., Arizona State University/The Biodesign Institute
12:15 p.m. – 12:35 p.m. EDT	SC07: Evaluation and Discovery of Early Detection Markers in Large-scale Prospective Population Cohorts Rudolf Kaaks, PhD., Division of Cancer Epidemiology, German Cancer Research Center
12:35 p.m. – 12:40 p.m. EDT	Q&A
12:40 p.m. – 1:00 p.m. EDT	SC08: Resources for Ovarian Cancer Discovery and Validation Studies Renée Fortner, Ph.D., Division of Cancer Epidemiology, German Cancer Research Center
1:00 p.m. – 1:05 p.m. EDT	Q&A
1:05 p.m. – 1:25 p.m. EDT	Break
1:25 p.m. – 3:15 p.m. EDT	Universal Cancer Screening: Pros and Cons Goal: The concept of universal cancer screening is gaining some traction. In this session we will explore opportunities and challenges related to this approach informed by the EDRN experience. Chair: Arul Chinnaiyan, M.D., Ph.D., University of Michigan
1:25 p.m. – 1:45 p.m. EDT	SC09: A Case for Multi-Cancer Testing Kenneth Kinzler, Ph.D., Johns Hopkins University School of Medicine
1:45 p.m. – 1:50 p.m. EDT	Q&A
1:50 p.m. – 2:10 p.m. EDT	SC10: Simultaneous Multi-Cancer Detection using a Cell-free Nucleic Acid Assay Eric Fung, M.D., Ph.D. GRAIL
2:10 p.m. – 2:15 p.m. EDT	Q&A
2:15 p.m. – 2:30 p.m. EDT	SC11: The Path to Multi-Cancer Screening Kathryn Lang, M.D., Guardant Health
2:30 p.m. – 2:35 p.m. EDT	Q&A
2:35 p.m. – 2:50 p.m. EDT	SC12: Decoding the means to cancer’s end Girish Putcha, M.D., Ph.D., Freenome
2:50 p.m. – 2:55 p.m. EDT	Q&A
2:55 p.m. – 3:15 p.m. EDT	Panel Discussion Sanford Markowitz, M.D., Case Western Reserve University Martin Sanda, M.D., Emory University Samir Hanash, M.D., Ph.D., The University of Texas MD Anderson Cancer Center Joshua LaBaer, M.D., Ph.D., Arizona State University/The Biodesign Institute
3:15 p.m. – 3:35 p.m. EDT	Break
3:35 p.m. – 4:15 p.m. EDT	SC13: Biomarkers and BIG Data Chair: Dan Crichton, M.S., NASA Jet Propulsion Laboratory Panel Discussion Dan Crichton, M.S., NASA Jet Propulsion Laboratory Ziding Feng, Ph.D., Fred Hutchinson Cancer Research Center Steven Skates, Ph.D., Massachusetts General Hospital Zhen Zhang, Ph.D., Johns Hopkins University School of Medicine Paul Boutros, Ph.D., University of California, Los Angeles Matthew Schabath, Ph.D., H. Lee Moffitt Cancer Center and Research Institute, Inc.